Reliable detection of GABA is important for studies in neuro-psychiatric diseases. In vivo 1H GABA resonances are extensively overlapped with the neighboring resonances including glutamate and glutamine. We present a new triple-focusing 1H MRS method which can fully resolve GABA 2.29-ppm and Glu 2.35 ppm signals at 3T.
PURPOSE
Alternations in the concentrations of primary inhibitory neurotransmitter, γ-aminobutyric acid (GABA), and major excitatory neurotransmitter, Glutamate (Glu), in the human brain occur in many neuro-psychiatric disorders.1 Given the importance of reliable and precise measurement of the GABA and Glu, a triple-refocusing scheme to separate GABA signal from Glu was reported previously.2 The report demonstrated capability of triple-refocusing scheme for the detection of GABA. Here we report a new GABA optimized triple-refocusing approach using a novel four-τ scheme that can completely resolve the GABA 2.29-ppm resonance from neighboring resonances and reliably quantify GABA and Glu at 3T.METHODS
The 1H MRS sequence used had three 180° RF pulses following a slice selective 90° excitation pulse. The first and third 180° pulses were slice selective (13.2 ms; bandwidth 1.3 kHz) and the second 180° pulse was non-slice selective. Volume-localized density-matrix simulations were conducted for optimizing the second 180° pulse duration and the triple-refocusing inter-RF pulse delay times τ1, τ2, τ3 and τ4 (Fig 1.) Restriction of τ1+τ3 = τ2+τ4 for forming an echo and total echo time (TE = τ1+τ2+τ3+τ4) less than 100ms were used for simulation. From ~350,000 calculated spectra, an optimal inter-RF pulse delay time set was obtained with the criteria: 1) largest GABA signal amplitude and most flat Glu signal around 2.29 ppm; 2) small apparent Glu signal linewidth around 2.35 ppm for better separation between Glu and GABA signals.
Six healthy adult subjects (3 male and 3 female, age 27±5) were recruited for the study. In vivo 1H MRS data were obtained with proposed triple-refocusing MRS from Medial Occipital (MO) and Left Occipital (LO). The voxel size was 23´23´23 mm3 for MO and 35x23x15 mm3 for LO. Data acquisition parameters included NEX=128 and TR=2 s (scan time 4 min). Data were acquired with a 32-channel head coil in a 3T whole-body scanner (Philips Medical Systems). T1w-MPRAGE was acquired and used for segmentation of gray matter and white matter contents within the voxels. Spectral fitting was performed, with LCModel software,3 using in-house calculated basis spectra of 20 metabolites. Metabolites were quantified with reference to water at 45 M. T2 relaxation effects were corrected using published T2 values.4 Two-tailed paired t-test was performed for each metabolite estimations between MO and LO. Effects for multiple comparisons were corrected by applying Bonferroni correction (p = 0.05/8 = 0.0063).
1. Tran T, Ross B, Lin A. Magnetic resonance spectroscopy in neurological diagnosis. Neurol Clin. 2008; 27: 21-60.
2. An Z, Ganji SK, Tiwari V, Choi C. Novel Triple-refocusing 1H MRS at 3T for detection of GABA in human brain in vivo. p2370, ISMRM 23rd Annual Meeting & Exhibition, Toronto, Canada, 2015.
3. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Res Med. 1993; 30: 672-9.
4. Ganji SK, Banerjee A, Patel AM, et al. T2 measurement of J-coupled metabolites in the human brain at 3T. NMR Biomed. 2012; 25: 523-9.
5. Puts NA, Edden RA. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc. 2012; 60: 29-41
6. Bhattacharyya PK, Phillips MD, Stone LA, Lowe MJ. In vivo magnetic resonance spectroscopy measurement of gray-matter and white-matter gamma-aminobutyric acid concentration in sensorimotor cortex using a motion-controlled MEGA point-resolved spectroscopy sequence. Magn Reson Imaging. 2011; 29: 374-9.
7. Ganji SK, An Z, et al. Measurement of Regional variation of GABA in the human brain by optimized point-resolved spectroscopy at 7T invivo. NMR Biomed. 2014; 27: 1167-1175.